Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 6150 participants.

Also called NCT04774159

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 6,150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04774159
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Australia, Belgium, Brazil, Canada, Ecuador, Germany, Netherlands, Switzerland, United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04774159. Randomized; quadruple masking; primary purpose treatment. Start 2021-05-06 (actual); primary completion 2029-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
Acronym
LEADER-PAD
Condition
Peripheral Arterial Disease
Condition
Atherosclerosis of Extremities
Condition
Inflammation
Intervention (Drug)
Colchicine 0.5 MG Oral Tablet
Intervention (Drug)
Colchicine-Placebo
Lead sponsor
Population Health Research Institute (class: other)

Record details

Record id
cardio:ct-nct04774159
Content hash
01080e3992e01387bbd65e416240d88213d68ffb6e91ec436cc4af8bc7b1a4e8